Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Completed

Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

NCT00134680

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Lombardi Cancer Institute, Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Siteman Cancer Center, Washington University St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer

NCT00615940

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Montefiore Medical Center Weiler Division Department New York, United States
  • Universitys Hospital Case Medical Center Cleveland, Ohio, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • AZ Klina, Oncology Department Brasschaat, Belgium
View all 20 locations
View Trial Details
Completed

A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab

NCT00875979

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Boca Raton, Florida, United States
  • Deerfield Beach, Florida, United States
  • Maywood, Illinois, United States
  • Indianapolis, Indiana, United States
View all 20 locations
View Trial Details
Completed

Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer

NCT00811369

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada
  • QE II Health Sciences Centre Halifax, Nova Scotia, Canada
  • Regional Cancer Program of the Hôpital régional de Sudbury Regional Hospital Greater Sudbury, Ontario, Canada
View all 13 locations
View Trial Details

Related conditions